Treatment Clinical Trials

534 recruitingLast updated: June 17, 2026

There are 534 actively recruiting treatment clinical trials across 52 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Tianjin, Tianjin Municipality, China, Toronto, Ontario, Canada, New York, New York, United States. Updated daily from ClinicalTrials.gov.


Treatment Trials at a Glance

534 actively recruiting trials for treatment are listed on ClinicalTrialsFinder across 6 cities in 52 countries. The largest study group is Not Applicable with 227 trials, with the heaviest enrollment activity in Tianjin, Toronto, and New York. Lead sponsors running treatment studies include Institute of Hematology & Blood Diseases Hospital, China, Centre for Addiction and Mental Health, and Shanghai Juncell Therapeutics.

Treatments under study

About Treatment Clinical Trials

Looking for clinical trials for Treatment? There are currently 41 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Treatment trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Treatment clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 534 trials

Recruiting

Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure

Lyme DiseaseChronic Lyme DiseasePregnancy Complications+3 more
Children's National Research Institute40 enrolled1 locationNCT06026969
Recruiting
Phase 2

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

DepressionDepressive DisorderMolecular Mechanisms of Pharmacological Action+10 more
National Institute of Mental Health (NIMH)50 enrolled1 locationNCT06511908
Recruiting
Not Applicable

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Treatment Resistant Depression
LivaNova6,800 enrolled101 locationsNCT03887715
Recruiting
Not Applicable

Cognitive Behavioral Therapy for Cancer-related Fatigue in Patients With Cancer Receiving Palliative Systemic Treatment

CancerPalliative Treatment
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)56 enrolled1 locationNCT06511518
Recruiting
Phase 1

Biological, Radiographic and Clinical Evaluation of Various Inter-Visit Root Canal Dressings in Retreatment Cases

Intracanal MedicationIntervention StudiesASA Physical Status I+2 more
Ain Shams University60 enrolled1 locationNCT07641933
Recruiting
Not Applicable

EFFECT OF NITI SYSTEMS AND XP-ENDO FINISHER ON POSTOPERATIVE PAIN

Postoperative Pain After Endodontic Treatment
BUSRA OZTURK80 enrolled2 locationsNCT07642596
Recruiting
Not Applicable

DBS for TRD With the Medtronic Percept PC

Major Depressive DisorderTreatment Resistant Depression
Helen Mayberg, MD10 enrolled1 locationNCT05773755
Recruiting
Not Applicable

Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension

AdrenalectomyPrimary Aldosteronism Due to Conn AdenomaRadiofrequency Ablation Treatment
University Hospital, Toulouse134 enrolled1 locationNCT07470580
Recruiting
Not Applicable

OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases

Liver MetastasesStereotactic Body Radiation TherapyMRI-guided Treatment
University of Wisconsin, Madison32 enrolled1 locationNCT04020276
Recruiting
Not Applicable

Deep Brain Stimulation for Psychosis

Treatment-Refractory Schizophrenia
Bradley Lega10 enrolled1 locationNCT06257056
Recruiting
Phase 4

A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

Acute Treatment of Migraine
Pfizer400 enrolled3 locationsNCT07609914
Recruiting
Phase 2

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Major Depressive Disorder (MDD)Depressive Disorder, Treatment-Resistant
ACADIA Pharmaceuticals Inc.153 enrolled21 locationsNCT07284667
Recruiting
Phase 3

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Acute Treatment of Migraine
Pfizer600 enrolled126 locationsNCT04743141
Recruiting
Phase 4

A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression

Depressive Disorder, Treatment-Resistant
Janssen Korea, Ltd., Korea47 enrolled6 locationsNCT07053345
Recruiting

Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy

InfertilityAcute Ovarian FailureEarly Menopause And Infertility In Females After Treatment For Childhood Cancer
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)100 enrolled1 locationNCT05440617
Recruiting
Not Applicable

Diagnosing Epilepsy To EffeCT Change

EpilepsyEpilepsy (Treatment Refractory)
Epiminder America, Inc.210 enrolled18 locationsNCT07110337
Recruiting
Phase 3

Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

Treatment-resistant Schizophrenia
Newron Pharmaceuticals SPA400 enrolled10 locationsNCT07184619
Recruiting
Not Applicable

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Treatment Resistant Depression
Abbott Medical Devices100 enrolled24 locationsNCT06423430
Recruiting
Not Applicable

Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment

ParentingSubstance Use TreatmentPerinatal Substance Use
University of Arkansas10 enrolled1 locationNCT07071766
Recruiting
Phase 1Phase 2

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

ParagangliomaPheochromocytomaSolid Tumor Cancer+19 more
Fundación de investigación HM25 enrolled1 locationNCT06607692